Soccer-Themed program aims to boost HIV prevention in men
NCT ID NCT07263048
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a program called PrEP & Soccer, run through CVS pharmacies, to help men learn about and start PrEP—a daily pill that prevents HIV. About 800 men aged 18-54 who are at risk for HIV will take part. Some pharmacies will offer personalized PrEP navigation and a soccer-themed pamphlet, while others provide only standard health information. The goal is to see if the program increases attendance at first PrEP appointments and improves HIV prevention awareness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PrEP navigation support and educational brochure
What this could lead to
If successful, this program could make it easier for men at risk of HIV to learn about and start PrEP, potentially reducing new infections.
What could go wrong
This is an early-stage implementation study, not a drug trial. The program may not increase PrEP use as hoped, and results may not apply to other settings or populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Miami
Miami, Florida, 33136, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact